<DOC>
	<DOCNO>NCT02294630</DOCNO>
	<brief_summary>Respiratory distress syndrome ( RDS ) , cause surfactant deficiency , lead cause mortality morbidity preterm infant . Intratracheal instillation , approve mean surfactant delivery , require endotracheal intubation mechanical ventilation attendant risk . Interventions decrease need intubation mechanical ventilation like noninvasive ventilation ( NIV ) include nasal continuous positive airway pressure , high flow nasal cannula nasal intermittent mandatory ventilation increasingly used initial respiratory support preterm neonates RDS improve outcomes . Aerosolized surfactant deliver NIV innovative promising concept treatment RDS - retaining advantage early surfactant alveolar recruitment obviate risk intubation mechanical ventilation . The investigator overall hypothesis treatment RDS aerosolize surfactant preterm infant undergo NIV safe feasible result short-term improvement oxygenation ventilation . The objective proposal perform single-center unblinded Phase II randomize clinical trial aerosolize surfactant treatment RDS preterm neonate undergo NIV . Funding Source - FDA-OOPD .</brief_summary>
	<brief_title>Aerosolized Surfactant Neonatal RDS</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Hyaline Membrane Disease</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<mesh_term>Beractant</mesh_term>
	<criteria>1 . Infants admit NICU Hutzel Women 's Hospital ( HWH ) /Children 's Hospital Michigan ( CHM ) 2 . Gestational age 240/7366/7 week 3 . Postnatal age ≤ 24 hour 4 . Clinical diagnosis RDS base ( ) presence least two four classic symptom ( need supplemental oxygen , tachypnea , intercostal retraction grunt ) , ( ii ) exclusion cause respiratory failure ( iii ) Clinician intent administer surfactant infant require intubation 5 . Respiratory support NIV ( CPAP NIPPV HFNC ) FiO2 ≥25 % PEEP ≥ 4 cmH20 HFNC rate ≥ 2 LPM ≤8 hour 6 . Written inform consent parent/guardian 1 . Previous receipt surfactant 2 . Infants respiratory distress unstable require immediate intubation 3 . Active air leak syndrome ( e.g . pneumothorax , pneumomediastinum ) 4 . Lethal congenital malformation ; death anticipate within first 3 day life ; decision withhold support 5 . Serious abdominal , cardiac , airway respiratory malformation include tracheal esophageal fistula , intestinal atresia , omphalocele , gastroschisis , pulmonary hypoplasia , diaphragmatic hernia 6 . Neuromuscular disorder result respiratory compromise</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>